Nexstem Pockets $3.5 Mn To Disrupt Neurotech Space

Deeptech startup Nexstem has secured $3.5 Mn (around INR 29.5 Cr) in an undisclosed funding round co-led by InfoEdge, Gruhas, Zupee and Smile Group.

The Bengaluru-based startup plans to use the fresh capital to boost its product ecosystem, expand IP portfolio and to disrupt the neurotech sector.

Founded in 2020 by Siddhant Dangi and Deepansh Goyal, Nexstem develops cutting-edge non-invasive brain computer interface (BCI) solutions. It aims to create a digital nervous system that records and interprets biosignals, enabling direct human body-to-technology communication, the statement added. 

The latest capital infusion will further advance the deployment of Nexstem’s biosignal infrastructure with an advanced BCI suite, making non-invasive neurotech solutions accessible across sectors besides healthcare, the company said in a statement. 

BCI technology enables direct communication between the human brain and external devices and can also restore lost motor functions and augment cognitive capabilities. 

“With this funding, we are excited to advance the deployment of our BCI ecosystem, which we believe will redefine how technology can address real-world challenges across diverse sectors. Our focus is on harnessing complex biosignal data from the human body, which will help us create better products, highly customised services and understand humans better than ever,” said Dangi. 

The startup’s product suite for BCI, ‘Instinct’, leverages an AI-powered onboard compute module that supports analysis for all kinds of biosignals from the human body, the statement said. 

Nexstem will also utilise the fund in expansion into American and European markets.

The development comes at a time when deeptech startups are gaining attention with the growing global demand for advanced technology. In further push to this sector, the Indian government is also reportedly planning to roll out the deeptech startup policy to provide long-term funds to companies. 

Note: We at Inc42 take our ethics very seriously. More information about it can be found here.